Celoxio

Celoxio is a medical technology company spun out from the University of Oxford, specializing in normothermic machine perfusion (NMP) for organ preservation. The company's primary focus is the development of a portable device designed to maintain kidneys at physiological temperature and supply them with oxygenated blood, nutrients, and drugs prior to transplantation. This technology aims to improve organ viability, allow for better assessment of organ function, and increase the pool of available donor kidneys. By mimicking the natural environment of the human body, the platform helps reduce the damage associated with traditional cold storage methods. In 2022, Celoxio was acquired by OrganOx, a leader in liver perfusion, to consolidate Oxford's NMP expertise and accelerate the commercialization of kidney preservation solutions. The integration allows for a unified approach to multi-organ preservation technologies.